Edwards Lifesciences, US28176E1082

Edwards Lifesciences stock heads into the open after a weaker session

Published on 09/25/2026 at 04:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, Edwards Lifesciences stock had a weaker session as the S&P 500 finished at 7,704.13, down less than 0.1 percent.

Fotorealistisches Katheterlabor mit Chirurgenteam bei minimalinvasivem Herzeingriff
Edwards Lifesciences Herzklappen-OP US28176E1082 im Katheterlabor mit Fluoroskopie-Bildschirmen und Chirurgenteam in Aktion, Illustration mit AI erstellt.

Edwards Lifesciences stock closed on the Nasdaq on September 24, 2026, with the session change and closing price not substantiated in the available market reports. The S&P 500 finished at 7,704.13, down less than 0.1 percent on the same session.

September 24, 2026 in numbers

Edwards Lifesciences Inc. (ISIN US28176E1082) traded during a session in which the broader US market ended marginally lower. US exchange volume reached 16.8 billion shares, compared with a 20-session average of 16.7 billion shares.

Investopedia reported that investors focused on US economic developments and broader market pressure during the session.

September 25, 2026 outlook

The US session is scheduled to begin today. Market conditions remain relevant for Edwards Lifesciences because the stock trades in the US healthcare sector, while the S&P 500 provides a same-session benchmark.

Disclaimer...

en | US28176E1082 | EDWARDS LIFESCIENCES | boerse | 70180298 | bgmi